International Conference on Microbicides 2000, Washington DC, 13-16 March 2000: Report

Reproductive Health Matters

Volumn 8, Issue 15, 2000, Pages 126-131

  Berer, Marge ^a  

^a NONE

Author keywords

Clinical trials; Condoms; HIV AIDs; Microbicides

Indexed keywords

ANTIINFECTIVE AGENT; BUFFER; DETERGENT; MICROBICIDE; NONOXINOL 9; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; AGENTS USED INTRAVAGINALLY;

CLINICAL TRIAL; CONDOM; CONFERENCE PAPER; CONTRACEPTION; FEMALE; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICAL ETHICS; PHASE 1 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; ANIMAL; ANIMAL MODEL; HEALTH PROMOTION; IN VITRO STUDY; ORGANIZATION AND MANAGEMENT; RECTAL DRUG ADMINISTRATION;

ADMINISTRATION, RECTAL; ANIMALS; ANTI-INFECTIVE AGENTS; CLINICAL TRIALS; CONDOMS; FEMALE; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; MALE; MODELS, ANIMAL; SEXUALLY TRANSMITTED DISEASES; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 0034189737     PISSN: 09688080     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-8080(00)90014-4     Document Type: Conference Paper

References (1)

1. For a thorough summary of the types of products under study, see: Hitchcock PJ, 2000. Topical microbicides. Sexually Transmitted Diseases. [In press]